prestige biologics octava fund

The Seoul Metropolitan Government on Sunday unveiled the design of a Ferris wheel, tentatively named Seoul Twin Eye, which it plans to complete by 2...

Korea Investment Corp. (KIC) posted a 7.12% return on total asset investments in the first eight months of this year, recouping about 40% of last ye...

South Korean investors are growing more interested in global high-yield bond funds, betting that the US Federal Reserve is likely to end its interes...

Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...

Eastspring Asset Management Korea Co., the Korean operation of Prudential plc’s asset management unit, is up for sale for about 100 billion wo...

South Korea’s sovereign wealth fund, banks and other private sector companies plan to pour £21 billion ($26.3 billion) in renewables, in...

Investors should carefully watch out for the probability of recession and how it will impact asset allocation strategies next year, experts said at ...

The venture capital funding crunch has continued through this year in South Korea but VCs have raised their stakes in select companies in the electr...

South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...

Korea Investment & Securities Co. announced on Friday it has signed a strategic partnership with Carlyle Group, one of the world's leading priva...

BARCELONA -- Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, is looking for acquisitions of new drugma...

Despite the challenging economic environment, there are still plenty of opportunities for profit in commercial real estate, notably through debt i...

South Korea’s startups last month saw investment rise for the first time this year.The Seoul-based Startup Alliance, a private support organiz...

Shinhan Finance, a subsidiary of South Korea's Shinhan Card in Kazakhstan, has attracted a $60 million investment from the International Finance Cor...

Samsung Biologics Co., the world's largest contract drug manufacturer, announced on Tuesday it has teamed up with global biotech venture capitalist ...

South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...

South Korean homegrown app store One Store Co. has attracted a 20-billion-won ($14.8-million) investment from Krafton Inc. The company's goal is to ...

South Korea’s poultry processing company Harim Group is set to sell off all its Hanjin KAL Co. shares its affiliate owns to secure capital for...

Korea Investment Corporation (KIC) entrusted most of its money for investments in alternative assets such as real estate and private equity to forei...

South Korean chemical material company SKC Ltd. is selling its unit for raw materials of polyurethane (PU), a chemical substance.The company’s...

Singapore-based private equity firm Flashlight Capital Partners Pte. said Monday that it has filed court injunctions against KT&G Corp., beginni...

South Korea’s SK Plasma on Tuesday said it signed a term sheet, or a nonbinding agreement on the basic terms and conditions of an investment, ...

South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liter...

South Korea's NeoCannBio, a medical cannabis startup backed by the Korea Institute of Science and Technology (KIST), announced on Tuesday that it ha...

South Korea's precursor manufacturer EcoPro Materials, aims to quadruple its production capacity by raising funds between 524 billion won ($390 mill...

South Korean startups and venture capitalists battered by chilled investor sentiment amid rising interest rates and slowing economic growth at home ...

Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...

Shinyoung Asset Management Co. has joined hands with Baillie Gifford & Co., a UK investment management firm, to launch a long-term growth stock ...

Samsung Biologics Co., the world’s largest contract drugmaker, said on Monday it has signed an agreement to produce $242 million worth of anti...

South Korean general trading company STX Corp. has said its largest shareholder is a local investment firm, refuting false reports swirling in the m...